Market revenue in 2021 | USD 706.8 million |
Market revenue in 2028 | USD 964.7 million |
Growth rate | 4.5% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Loop Mediated Isothermal Amplification (LAMP) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.63% in 2021. Horizon Databook has segmented the Japan gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
Japan being one of the technically advanced countries is witnessing significant growth in the gene amplification technologies market. The presence of key players such as Takara Bio Inc., the development of new products, and active engagement of research and academic institutes are some key driving forces of the country's market growth.
For instance, in January 2019, a research study was established by researchers from the National Institute of Infectious Diseases along with Showa General Hospital for the development and evaluation of a novel real-time RT-PCR assay for the detection of the H9N2 subtype of avian influenza A viruses (AIV).
Horizon Databook provides a detailed overview of country-level data and insights on the Japan gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into Japan gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account